Latham & Watkins has advised Grünenthal GmbH, a leading pharmaceutical company in the area of pain management, on the issuance of a €500 million bond aggregate principal amount of 4.625% senior secured notes due 2031.
Grünenthal was advised in-house by a legal team led by Sebastian Köhler (General Counsel), with Sabine König (Senior Legal Counsel), Megan Renze (Senior Legal Counsel US), and Hannah Engels (Global Compliance and Responsibility Officer).
The Latham team was led by Frankfurt capital markets partner Alexander Lentz and Munich capital markets partner Rüdiger Malaun, with Frankfurt counsel Gregory Walker, and associates Peter Neuböck and Laura Neumann.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
